791 related articles for article (PubMed ID: 27133053)
1. Improved tumor targeting and antitumor activity of camptothecin loaded solid lipid nanoparticles by preinjection of blank solid lipid nanoparticles.
Jang DJ; Moon C; Oh E
Biomed Pharmacother; 2016 May; 80():162-172. PubMed ID: 27133053
[TBL] [Abstract][Full Text] [Related]
2. Development of pH-Sensitive Cationic PEGylated Solid Lipid Nanoparticles for Selective Cancer-Targeted Therapy.
Chuang CH; Wu PC; Tsai TH; Fang YP; Tsai YH; Cheng TC; Huang CC; Huang MY; Chen FM; Hsieh YC; Lin WW; Tsai MJ; Cheng TL
J Biomed Nanotechnol; 2017 Feb; 13(2):192-03. PubMed ID: 29377649
[TBL] [Abstract][Full Text] [Related]
3. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
[TBL] [Abstract][Full Text] [Related]
4. Preparation of camptothecin-loaded targeting nanoparticles and their antitumor effects on hepatocellular carcinoma cell line H22.
Yang A; Liu Z; Yan B; Zhou M; Xiong X
Drug Deliv; 2016 Jun; 23(5):1699-706. PubMed ID: 25148540
[TBL] [Abstract][Full Text] [Related]
5. Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability.
Sun J; Bi C; Chan HM; Sun S; Zhang Q; Zheng Y
Colloids Surf B Biointerfaces; 2013 Nov; 111():367-75. PubMed ID: 23856543
[TBL] [Abstract][Full Text] [Related]
6. Preparation and investigation of indirubin-loaded SLN nanoparticles and their anti-cancer effects on human glioblastoma U87MG cells.
Rahiminejad A; Dinarvand R; Johari B; Nodooshan SJ; Rashti A; Rismani E; Mahdaviani P; Saltanatpour Z; Rahiminejad S; Raigani M; Khosravani M
Cell Biol Int; 2019 Jan; 43(1):2-11. PubMed ID: 30080277
[TBL] [Abstract][Full Text] [Related]
7. Protective effects on myocardial infarction model: delivery of schisandrin B using matrix metalloproteinase-sensitive peptide-modified, PEGylated lipid nanoparticles.
Shao M; Yang W; Han G
Int J Nanomedicine; 2017; 12():7121-7130. PubMed ID: 29026305
[TBL] [Abstract][Full Text] [Related]
8. Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies.
Wang S; Chen T; Chen R; Hu Y; Chen M; Wang Y
Int J Pharm; 2012 Jul; 430(1-2):238-46. PubMed ID: 22465546
[TBL] [Abstract][Full Text] [Related]
9. Ceramide and N,N,N-Trimethylphytosphingosine-Iodide (TMP-I)-Based Lipid Nanoparticles for Cancer Therapy.
Balakrishnan P; Song CK; Jahn A; Cho HJ
Pharm Res; 2016 Jan; 33(1):206-16. PubMed ID: 26337769
[TBL] [Abstract][Full Text] [Related]
10. Development and evaluation of camptothecin loaded polymer stabilized nanoemulsion: Targeting potential in 4T1-breast tumour xenograft model.
Sugumaran A; Ponnusamy C; Kandasamy P; Krishnaswami V; Palanichamy R; Kandasamy R; Lakshmanan M; Natesan S
Eur J Pharm Sci; 2018 Apr; 116():15-25. PubMed ID: 28987538
[TBL] [Abstract][Full Text] [Related]
11. Primary Studies on Construction and Evaluation of Ion-Sensitive in situ Gel Loaded with Paeonol-Solid Lipid Nanoparticles for Intranasal Drug Delivery.
Sun Y; Li L; Xie H; Wang Y; Gao S; Zhang L; Bo F; Yang S; Feng A
Int J Nanomedicine; 2020; 15():3137-3160. PubMed ID: 32440115
[TBL] [Abstract][Full Text] [Related]
12. Nanocarrier improves the bioavailability, stability and antitumor activity of camptothecin.
Tang XJ; Han M; Yang B; Shen YQ; He ZG; Xu DH; Gao JQ
Int J Pharm; 2014 Dec; 477(1-2):536-45. PubMed ID: 25445532
[TBL] [Abstract][Full Text] [Related]
13. Biofunctionalized polymer-lipid supported mesoporous silica nanoparticles for release of chemotherapeutics in multidrug resistant cancer cells.
Zhang X; Li F; Guo S; Chen X; Wang X; Li J; Gan Y
Biomaterials; 2014 Apr; 35(11):3650-65. PubMed ID: 24462359
[TBL] [Abstract][Full Text] [Related]
14. A stabilizer-free and organic solvent-free method to prepare 10-hydroxycamptothecin nanocrystals: in vitro and in vivo evaluation.
Yang X; Liu Y; Zhao Y; Han M; Guo Y; Kuang H; Wang X
Int J Nanomedicine; 2016; 11():2979-94. PubMed ID: 27382284
[TBL] [Abstract][Full Text] [Related]
15. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo evaluation of SN-38 nanocrystals with different particle sizes.
Chen M; Li W; Zhang X; Dong Y; Hua Y; Zhang H; Gao J; Zhao L; Li Y; Zheng A
Int J Nanomedicine; 2017; 12():5487-5500. PubMed ID: 28814865
[TBL] [Abstract][Full Text] [Related]
17. Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug.
Jain A; Agarwal A; Majumder S; Lariya N; Khaya A; Agrawal H; Majumdar S; Agrawal GP
J Control Release; 2010 Dec; 148(3):359-67. PubMed ID: 20854859
[TBL] [Abstract][Full Text] [Related]
18. Camptothecin in sterically stabilized phospholipid micelles: a novel nanomedicine.
Koo OM; Rubinstein I; Onyuksel H
Nanomedicine; 2005 Mar; 1(1):77-84. PubMed ID: 17292061
[TBL] [Abstract][Full Text] [Related]
19. Chitosan stabilized camptothecin nanoemulsions: Development, evaluation and biodistribution in preclinical breast cancer animal mode.
Natesan S; Sugumaran A; Ponnusamy C; Thiagarajan V; Palanichamy R; Kandasamy R
Int J Biol Macromol; 2017 Nov; 104(Pt B):1846-1852. PubMed ID: 28545970
[TBL] [Abstract][Full Text] [Related]
20. Surface-modified silica nanoparticles for tumor-targeted delivery of camptothecin and its biological evaluation.
Botella P; Abasolo I; Fernández Y; Muniesa C; Miranda S; Quesada M; Ruiz J; Schwartz S; Corma A
J Control Release; 2011 Dec; 156(2):246-57. PubMed ID: 21756949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
